BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18815149)

  • 1. Review of the best case series methodology: best case series results of East-West Cancer Center.
    Yoo HS; Cho CK; Hong MS
    Integr Cancer Ther; 2008 Sep; 7(3):182-8. PubMed ID: 18815149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer outcomes at the Hufeland (complementary/alternative medicine) klinik: a best-case series review.
    Jacobson JS; Grann VR; Gnatt MA; Hibshoosh H; Austin JH; Millar WS; Neugut AI
    Integr Cancer Ther; 2005 Jun; 4(2):156-67. PubMed ID: 15911928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative tumor board: a case report and discussion from East-West Cancer Center.
    Park HM; Kim SY; Jung IC; Lee YW; Cho CK; Yoo HS
    Integr Cancer Ther; 2010 Jun; 9(2):236-45. PubMed ID: 20498130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The National Cancer Institute best case series program: a summary of cases of cancer patients treated with unconventional therapies in India.
    Olaku O; Zia F; Santana JM; White JD
    Integr Cancer Ther; 2013 Sep; 12(5):385-92. PubMed ID: 23355475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer patients treated with the Banerji protocols utilising homoeopathic medicine: a Best Case Series Program of the National Cancer Institute USA.
    Banerji P; Campbell DR; Banerji P
    Oncol Rep; 2008 Jul; 20(1):69-74. PubMed ID: 18575720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of a person-centered approach in caring for patients with cancer: a perspective from the UCLA center for East-West medicine.
    Hui KK; Hui EK; Johnston MF
    Integr Cancer Ther; 2006 Mar; 5(1):56-62. PubMed ID: 16484714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translational research in cancer complementary and alternative medicine: the National Cancer Institute's Best Case Series Program.
    Lee CO
    Clin J Oncol Nurs; 2004 Apr; 8(2):212-4. PubMed ID: 15108425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of "immunoaugmentative therapy (IAT)": an unconventional cancer treatment.
    Pfeifer BL; Jonas WB
    Integr Cancer Ther; 2003 Jun; 2(2):112-9. PubMed ID: 15035898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Cancer Institute designation predicts improved outcomes in colorectal cancer surgery.
    Paulson EC; Mitra N; Sonnad S; Armstrong K; Wirtalla C; Kelz RR; Mahmoud NN
    Ann Surg; 2008 Oct; 248(4):675-86. PubMed ID: 18936581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A statewide community cancer center videoconferencing program.
    Dickson-Witmer D; Petrelli NJ; Witmer DR; England M; Witkin G; Manzone T; Napoletano J; Strusowski P; Spellman J; Smith D
    Ann Surg Oncol; 2008 Nov; 15(11):3058-64. PubMed ID: 18712451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of rigorous scientific evaluation in the use and practice of complementary and alternative medicine.
    Kantor M
    J Am Coll Radiol; 2009 Apr; 6(4):254-62. PubMed ID: 19327658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sweet bee venom pharmacopuncture treatment for chemotherapy-induced peripheral neuropathy: a case series.
    Park JW; Jeon JH; Yoon J; Jung TY; Kwon KR; Cho CK; Lee YW; Sagar S; Wong R; Yoo HS
    Integr Cancer Ther; 2012 Jun; 11(2):166-71. PubMed ID: 21715371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of standardized Rhus verniciflua stokes extract as complementary therapy on metastatic colorectal cancer: a Korean single-center experience.
    Lee SH; Choi WC; Yoon SW
    Integr Cancer Ther; 2009 Jun; 8(2):148-52. PubMed ID: 19679623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Best case series 'SWAT' teams: AHRQ/NCCAM/RAND partnership facilitates review of CAM cancer treatments.
    Muscat M
    Altern Ther Health Med; 2001; 7(5):24-6. PubMed ID: 11565398
    [No Abstract]   [Full Text] [Related]  

  • 16. Survival impact of integrative cancer care in advanced metastatic breast cancer.
    Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J
    Breast J; 2009; 15(4):357-66. PubMed ID: 19470134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life and complementary and alternative medicine use among cancer patients in Turkey.
    Can G; Erol O; Aydiner A; Topuz E
    Eur J Oncol Nurs; 2009 Sep; 13(4):287-94. PubMed ID: 19395312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National Cancer Database report on cancer of the head and neck: 10-year update.
    Cooper JS; Porter K; Mallin K; Hoffman HT; Weber RS; Ang KK; Gay EG; Langer CJ
    Head Neck; 2009 Jun; 31(6):748-58. PubMed ID: 19189340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
    Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
    Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of biofield therapies in cancer care.
    Pierce B
    Clin J Oncol Nurs; 2007 Apr; 11(2):253-8. PubMed ID: 17573275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.